1Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor in human disease[J]. N Engl J Med, 2000, 342(18): 1350-1358.
2Imamura T, et al. Smad6 inhibits signaling by the TGF-β superfamily[J]. Nature, 1997, 389 (6651): 622-626.
3Nakao A, Takase M, Nishihara A, etal. Identifieation of Smad7, a TGF-β-inducible antagonist of TGF-β-signaling [J]. Nature, 1997, 389(6651): 631-635.
4Yoo YD, Choi JY, Lee SJ, et al. TGF-beta-induced cell-cycle arrest through the p21 (WAF1/C1P1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells[J]. Int J Cancer, 1999, 83(4): 512-517.
5Lavarone A , Massague J. Repression of CDK activitor edc25A and cell-cycle arrest by cytokine TGF-β cells in lacking CDK inhibitor p15[J]. Nature, 1997, 387(6631): 417-422.
6Grady WM., Myeroff LL, Swinler S E, et al. Mutational inactivation of transforming growth factor TGF-β receptor type Ⅱ in microsatellite stable colon cancers[J]. Cancer Res, 1999, 59(2): 320-324.
7Goggins M. , Shekher M, Turnacioglu K, et al. Genetic alterations of the transforming growth factor-(receptor genes in pancteafic and biliary adenocarcinomas[J]. Cancer Res, 1998, 58(23): 5329-5332.
8Kang SH, Bang YJ, Im YH, et al. Transcriptional repression of the transforming growth factor type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer[J]. Oncogene, 1999, 18(51): 7280-7286.
9Kleeff J, Ishiwata T, Maruyana H, et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer[J]. Oncogene, 1999, 18(39): 5363-5372.
10Hu W , Wu W, Nash MA, et al. Anomalies of TGF-beta postreceptor signaling pathway in ovarian cancer cell line[J]. Anticancer Res, 2000, 20(2A): 729-733.
